VOR
Vor Biopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
VOR fundamentals
Vor Biopharma (VOR) released its earnings on Nov 13, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -121.63 (YoY -30307.50%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-121.63
-30307.50%
Report date
Nov 13, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Vor Biopharma (VOR) key financial stats and ratios, covering profitability, financial health, and leverage.
Vor Biopharma (VOR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Vor Biopharma (VOR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Vor Biopharma (VOR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Vor Biopharma (VOR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Vor Biopharma (VOR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Vor Biopharma's management provide for the next earnings period?What factors drove the changes in Vor Biopharma's revenue and profit?What were the key takeaways from Vor Biopharma’s earnings call?What is Vor Biopharma's gross profit margin?What is the revenue and EPS growth rate for Vor Biopharma year over year?What were the key takeaways from Vor Biopharma's earnings call?What is the market's earnings forecast for Vor Biopharma next quarter?What does Vor Biopharma do and what are its main business segments?
